Five Star Equities Issues New Research Reports on HOV, IMUC, LULU and XLSadmin
Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Hovnanian Enterprises, Inc. (NYSE: HOV) shares spiked 5.81 percent to close at $5.28 a share Thursday. The stock traded between $5.07 and $5.28 on volume 8.71 million shares traded. The company reported a net income of $32.8 million for the fourth quarter of fiscal 2013, compared to a net loss of $84.4 million a year ago. Shares of Hovnanian Enterprises have fallen approximately 25.0 percent year-to-date.
Get more information on Hovnanian Enterprises and free access to the in-depth equity report at:
ImmunoCellular Therapeutics Ltd. (NYSEMKT: IMUC) shares plunged 59.56 percent to close at $1.10 a share Thursday. The stock traded between $0.98 and $1.19 on volume 21.35 million shares traded. The company announced results from a Phase II study of ICT-107 that showed the vaccine “did not reach statistical significance in the intent-to-treat population”. Shares of ImmunoCellular have gained approximately 55.0 percent year-to-date.
Get more information on ImmunoCellular and free access to the in-depth equity report at:
Lululemon Athletica Inc. (NASDAQ: LULU) shares dropped 11.65 percent to close at $60.39 a share Thursday. The stock traded between $60.31 and $64.38 on volume 25.61 million shares traded. The company forecasts revenues for the fourth quarter to be in the range of $535 million to $540 million, which fell short of analysts’ estimates of $689 million, according to data from FactSet. Shares of Lululemon Athletica have gained approximately 60.0 percent year-to-date.
Get more information on Lululemon Athletica and free access to the in-depth equity report at:
Exelis Inc. (NYSE: XLS) shares gained 8.37 percent to close at $18.91 a share Thursday. The stock traded between $18.64 and $19.19 on volume 3.47 million shares traded. The company has announced plans to spin-off its military and government services business, currently called Exelis Mission Systems. Shares of Exelis have gained approximately 65.0 percent year-to-date.
Get more information on Exelis and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Posted: December 13th, 2013 under ACCESSWIRE.